FAT, E-cadherin, β catenin, HER 2/neu, Ki67 immunoexpression, and histological grade in intrahepatic cholangiocarcinoma

Journal of Clinical Pathology

Volumn 58, Issue 12, 2005, Pages 1249-1254

  Settakorn, J ^a   Kaewpila, N ^a   Burns, G F ^b   Leong, A S Y ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN; PROTEIN FAT; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE TRANSPORT; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BETA CATENIN; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CADHERINS; CELL NUCLEUS; CHOLANGIOCARCINOMA; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 28644441429     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.026575     Document Type: Article

References (26)

1. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1 : epidemiology and etiology. J Gastroenterol Hepatol 2002;17:1049-55.
2. Srivatanakul P, Parkin DM, Jiang YZ, et al. The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study. Cancer 1991;68:2411-17.
3. Ishak KG, Goodman ZD, Stocker JT. Tumors of the liver and intrahepatic bile ducts. In: Rosai J, Sobin LH, eds. Atlas of tumor pathology, 3rd series. Washington, DC: AFIP, 2001:245-70.
4. Okuda K, Kubo Y, Okazaki N, et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 1977;39:232-46.
5. Anthony PP. Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans. J Pathol 1973;110:37-48.
6. Kajiyama K, Maeda T, Takenaka K, et al. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of "scirrhous-type" and "nonscirrhous-type" growth. Am J Surg Pathol 1999;23:892-902.
7. Nakanuma Y, Sripa B, Vatanasapt V, et al. Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA, eds. WHO classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000:173-80.
8. Terada T, Ashida K, Endo K, et al. C-ERBB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma. Histopathology 1998;33:325-31.
9. Suzuki H, Isaii S, Pairojkul C, et al. Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan. J Hepatobiliary Pancreat Surg 2000;7:206-11.
10. Chow NH, Huang SM, Chan SH, et al. Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract. Anticancer Res 1995;15:1055-9.
11. Ito Y, Takeda T, Sasaki Y, et al. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma. Pathol Res Pract 2001;197:95-100.
12. Ukita Y, Kato M, Terada T. Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry. J Hepatol 2002;36:780-5.
13. Aishima SI, Taguchi KI, Sugimachi K, et al. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. Histopathology 2002;40:269-78.
14. Endo K, Yoon BI, Pairojkul C, et al. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology 2002;36:439-50.
15. Dunne J, Hanby AM, Poulsom R, et al. Molecular cloning and tissue expression of FAT, the human homologue of the drosophila FAT gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics 1995;30:207-23.
16. Mahoney PA, Weber U, Onofrechuk P, et al. The FAT tumor suppressor gene in drosophila encodes a novel member of the cadherin gene superfamily. Cell 1991;67:853-68.
17. Angst BD, Marcozzi C, Magee AI. The cadherin superfamily: diversity in form and function. J Cell Sci 2001;114:629-41.
18. Adler PN, Charlton J, Liu J. Mutations in the cadherin superfamily member gene dachsous cause a tissue polarity phenotype by altering frizzled signaling. Development 1998;125:959-68.
19. Chang HJ, Jee CD, Kim WH. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis. Am J Surg Pathol 2002;26:758-66.
20. Ochiai A, Akimoto S, Kanai Y, et al. c-erbB-2 gene product associates with catenins in human cancer cells. Biochem Biophys Res Commun 1994;205:73-8.
21. Ashida K, Terada T, Kitamura Y, et al. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 1998;27:974-82.
22. Sormunen R, Leong AS-Y, Vaaraniemi J, et al. E-cadherin and beta-catenin immunolocalization in infiltrating ductal carcinoma of the breast correlated with selected prognostic indices. J Pathol 1999;187:416-23.
23. Sugimachi K, Taguchi K, Aishima S, et al. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol 2001;14:900-5.
24. Kanai Y, Ochiai A, Shibata T, et al. C-erbb-2 gene product directly associates with beta-catenin and plakoglobin. Biochem Biophys Res Commun 1995;208:1067-72.
25. Wood B, Leong AS-Y. Cell adhesion proteins-biology, detection and applications. Pathology 2003;35:101-6.
26. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997;278:1043-50.